Categories: Health

Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery

NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ — Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with AstraZeneca to advance AI-powered drug discovery in immunology.

- Advertisement -

The partnership will combine Algen’s cutting-edge functional genomics and machine learning platform with AstraZeneca’s deep scientific expertise and global R&D capabilities. Together, the companies aim to identify and validate novel therapeutic targets for immune-mediated and inflammatory diseases, accelerating the discovery of next-generation medicines.

- Advertisement -

Harry Robb, Principal at Lifespan Vision Ventures, said “We are thrilled to see Algen Biotechnologies achieve this important milestone. The team has built a truly differentiated platform that integrates CRISPR-based functional screening with advanced AI analytics to uncover disease-relevant biology at scale. This collaboration with AstraZeneca underscores the strength of Algen’s technology and its potential to transform drug discovery.”

- Advertisement -

As an early investor, Lifespan Vision Ventures is proud to support Algen Biotechnologies in its mission to advance transformative therapies that improve patient outcomes in age-related diseases and extend healthspan.

- Advertisement -

About Algen Biotechnologies

- Advertisement -

Algen Biotechnologies is a precision therapeutics company redefining drug discovery at the intersection of CRISPR gene modulation and artificial intelligence. Founded by Chun-Hao Huang and Christine Du as a spin-out from Nobel laureate Jennifer Doudna’s lab at UC Berkeley, Algen combines deep learning with high-throughput functional genomics to identify novel therapeutic targets. Its proprietary, end-to-end platform AlgenBrain™ integrates advanced computational models with scalable, single-cell experimental systems to decode causal disease biology and accelerate the development of next-generation therapies. Algen is headquartered in San Francisco, CA.

- Advertisement -

For more information, visit www.algenbio.com.

- Advertisement -

About Lifespan Vision Ventures

- Advertisement -

Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology and longevity companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders advancing science-driven solutions that promote healthy aging and extend human vitality.

- Advertisement -

Contact: info@lifespanvision.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1780796/LifeSpan_Vision_Ventures_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/lifespan-backed-algen-biotechnologies-partners-with-astrazeneca-to-advance-ai-drug-discovery-302579935.html

- Advertisement -
PRNW Agency

Recent Posts

CATALYX SPACE SECURES $5.4 MILLION SEED ROUND TO BUILD FOR THE NEXT ERA OF ORBITAL LOGISTICS

Catalyx is building the complete back-end infrastructure for space: hardware, software, and operations that make…

47 minutes ago

Pakistan Engineering Council Partners with MindHYVE.ai to Launch Pakistan’s First AI-Driven Continuing Professional Development (CPD) Ecosystem

ISLAMABAD, Oct. 30, 2025 /PRNewswire/ -- With AI-powered education forecast to exceed USD 50 billion…

47 minutes ago

IOC President Kirsty Coventry: In 100 days Italian spirit and passion will shine through at Milano Cortina 2026

Written by IOC President Kirsty Coventry30 October 2025 - In just 100 days, the eyes…

2 hours ago

IOC Statement on the Olympic Esports Games

30 October 2025 – The initiative of the Olympic Esports Games has created a great…

2 hours ago

Canva Launches Creative Operating System

Next era of Canva combines a supercharged Visual Suite, world-first design AI, and powerful tools…

4 hours ago

Phibro Animal Health Corporation Announces National Launch of Restoris Piezoelectric Dental Gel for Dogs

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation is proud to announce the national launch of Restoris™…

4 hours ago